+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany

  • ID: 2588295
  • Report
  • Region: Germany
  • 142 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany

Summary

The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Germany. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Germany. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by a team of industry experts.

Germany is a mature healthcare market, with a strong focus on pharma R&D, production, and government policies supporting higher healthcare expenditure. In 2017, Germany spent $5,728 per capita on healthcare, which was higher than the OECD average of $4,069 per capita. In 2010, Germany had pharmaceutical sales of $39.4B. This increased to $40B in 2016. The market value is expected to reach $40.5B in 2022, growing at a Compounded Annual Growth Rate (CAGR) of 0.25%. The German medical device market was valued at $28B in 2015, which increased to $33.7B in 2020, growing at a CAGR of 3.7%.The increasing elderly population and associated disease burden are expected to drive the growth of the pharmaceutical market. However, the government initiated price-cap agreements to reduce healthcare expenditure have limited growth. The German healthcare system is characterized by universal insurance coverage, good accessibility to healthcare facilities, and adequate healthcare reimbursement. Germany offers more than 30 specialized cluster networks focusing on continuous innovation and R&D.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Germany, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Merck, Bayer, Pfizer, Boehringer Ingelheim and Novartis) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Fresenius, GE Healthcare, Essilor and B Braun)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Germany
  • Porter’s five forces analysis for pharmaceutical and medical devices market of Germany
  • An insightful review of the reimbursement and regulatory landscape, of which analysis include details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in Germany healthcare market.
Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving the Germany healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in Germany healthcare market.
Note: Product cover images may vary from those shown
2 of 3
  • Executive Summary
  • Overview of Pharmaceutical Market
  • Overview of Medical Device Market
  • Deals Analysis
  • Porter’s Five Forces Model
  • Market Access
  • Country Healthcare Landscape
  • Opportunities and Challenges
  • Appendix
List of Tables
  • Table 1: Pharmaceutical Market, Germany, Sales of Patented Drug Products by Major Therapeutic Class ($m), 2016
  • Table 2: Medical Device Market, Germany, Revenue by Segment ($B), 2018
  • Table 3: Cardiovascular Devices , Germany, Revenue ($M) and Market Share (%) of Major Companies
  • Table 4: IVD Market, Germany, Revenue ($M) and Market Share (%) of Major Companies
  • Table 5: Wound Care Management Market, Germany, Revenue ($M) and Market Share (%) of Major Companies
  • Table 6: Orthopedic Devices Market, Germany, Revenue ($M) and Market Share (%) of Major Companies
  • Table 7: Patent Fees, Germany, 2018
  • Table 8: Trademark Fees, Germany, 2018
  • Table 9: Requirements of Advertising of Pharmaceutical Products Through Mass Media
  • Table 10: Label of a Pharmaceutical Product
  • Table 11: Labeling and Packaging Leaflet
List of Figures
  • Figure 1: Pharmaceutical Market, Germany, Revenue ($B), 2010-2017
  • Figure 2: Medical Device Market, Germany, Revenue ($B), 2015-2020
  • Figure 3: Number of Deals (2018-2019)
  • Figure 4: 2018-19 Deal Overview By Region
  • Figure 5: Country Profile, Germany, 2018
  • Figure 6: Pharmaceutical Market, Germany, Revenue ($B), 2010-2017
  • Figure 7: Pharmaceutical Market, Germany, Revenue Forecast ($B), 2018-2022
  • Figure 8: Pharmaceutical Market, Germany, Pharmaceutical Exports
  • Figure 9: Pharmaceutical Market, Germany, Top Export Partners
  • Figure 10: Pharmaceutical Market, Germany, Pharmaceutical Imports
  • Figure 11: Pharmaceutical Market, Germany, Top Import Partners
  • Figure 12: Pharmaceutical Market, Germany, Supply Channels
  • Figure 13: Generics Market, Germany, Revenue ($B), 2010-2016
  • Figure 14: Pharmaceutical OTC Market, Germany, Revenue ($B), 2010-2017
  • Figure 15: Major OTC Drug Classes (Share%), Germany, 2017
  • Figure 16: Government Funded Biosimilars, Germany, 2017
  • Figure 17: Pharmaceutical Market, Germany, Sales of Patented Drug Products by Major Therapeutic Class ($B), 2016
  • Figure 18: Pharmaceutical Market, Major Players, Germany
  • Figure 19: Medical Device Market, Germany, Revenue ($B), 2015-2020
  • Figure 20: Medical Device Market, Germany, Revenue Forecast ($B), 2021-2025
  • Figure 21: Medical Device Market, Germany, Revenue by Segment ($B), 2018
  • Figure 22: Cardiovascular Devices Market, Germany, Revenue ($B), 2015-2022
  • Figure 23: Cardiovascular Devices Market, Germany, Market Share of Major Players (%)
  • Figure 24: IVD Market, Germany, Revenue ($B), 2015-2022
  • Figure 25: IVD Market, Germany, Market Share of Major Players (%)
  • Figure 26: Wound Care Management Market, Germany, Revenue ($B), 2015-2022
  • Figure 27: Wound Care Management Market, Germany, Market Share of Major Players (%)
  • Figure 28: Orthopedic Market, Germany, Revenue ($B), 2015-2022
  • Figure 29: Orthopedic Devices Market, Germany, Market Share of Major Players (%)
  • Figure 30: Ophthalmic Devices Market, Germany, Revenue ($B), 2015-2022
  • Figure 31: Ophthalmic Devices Market, Germany, Market Share of Major Players (%)
  • Figure 32: Diagnostic Market, Germany, Revenue ($B), 2015-2018
  • Figure 33:Diagnostic Market, Germany, Revenue Forecast ($B), 2019-2022
  • Figure 34: Medical Device Market - Major Players
  • Figure 35: Deal Value and Deal Count, Pharmaceutical Market, Germany, 2018-2019
  • Figure 36: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Germany, 2018-2019
  • Figure 37: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Germany, 2018-2019
  • Figure 38: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, Germany, 2018-2019
  • Figure 39: Top Five Therapy Areas by Deal Number, Pharmaceutical Market, Germany, 2018-2019
  • Figure 40: M&A Deals by Therapy Area, Pharmaceutical Market, Germany, 2018-2019 (by value and by number)
  • Figure 41: Venture Financing Deals by Therapy Area, Pharmaceutical Market Germany, 2018-2019 (by value and by number)
  • Figure 42: Medical Device Market Deals, Germany, 2018-2019(by deal value, $M)
  • Figure 43: Medical Device Market Deals, Germany, 2018 -2019(by deal count)
  • Figure 44: Medical Device Market Deals Share (by deal count), Germany, 2018 -2019
  • Figure 45: Medical Device Market Deals Share (by deal value), Germany, 2018 -2019
  • Figure 46: Top Five Therapy Areas by Deal Value, Medical Device, Germany, 2018-2019
  • Figure 47: Top Five Therapy Areas by Deal Number, Medical Device, Germany, 2018-2019
  • Figure 48: M&A Deals by Therapy Area, Medical Device, Germany, 2018-2019 (by number)
  • Figure 49: Venture Financing Deals by Therapy Area, Medical Device, Germany, 2018-2019 (by value and by number)
  • Figure 50: Private Equity Deals by Therapy Area, Medical Device Germany, 2018-2019(By number)
  • Figure 51: Healthcare System, Germany, 2018
  • Figure 52: Regulatory Authorities, Reimbursement Process, 2018
  • Figure 53: Reimbursement Process, Germany, 2018
  • Figure 54: Number of SHI Providers , Germany, 2010-2018
  • Figure 55: PKV-Aging Provisions ($B), 2006-2016, Germany
  • Figure 56: OOP Expenditure (% of total expenditure on health)
  • Figure 57: Annual Rate of Change (%), Consumer Price Index
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
The Healthcare Market of Germany is a Mature Market. The Presence of Well-Defined Regulatory Norms, Strong Research and Development Capabilities along with the Availability of Technically Qualified Professionals, Growing Prevalence of Chronic Aliments and Universal Healthcare Coverage together Contribute towards Growth of the Market. However, Instability of the Eurozone Limits the Growth Opportunities.

In 2012, the German pharmaceutical market was valued at $51.5 billion (€40.5 billion). The market is expected to reach $65.6 billion (€51 billion) in 2020 at a Compound Annual Growth Rate (CAGR) of 3.3% during 2013–2020. Germany is the largest healthcare market among the European Union (EU) member states. The presence of well-established regulatory norms, government’s healthcare initiatives, and the availability of infrastructure to support pharmaceutical companies contribute towards market growth. The German government promotes the advancement of new, superior and innovative technologies in all sectors and industries including the pharmaceutical industry. Strong Research and Development (R&D) capabilities and availability of technically qualified professionals contribute towards the growth of the German healthcare set-up.

The German Research Foundation (Deutsch Forschung Gründung, DFG) is a self-governing organization with the aim to encourage science and technology and consequently promote research. Growing prevalence of chronic ailments, along with the country’s increasing elderly population also account for growth of the German pharmaceutical market. Increased public awareness of health issues, a common regulatory procedure for the market authorization of drugs among the EU member states offers growth opportunities for the pharmaceutical market of Germany. Launch of novel products post 2014-2015 will also act as a market driver. With the growing demands of the eurozone, the government is focused on reducing the healthcare expenditure by regulating reimbursement and pricing policies through cost-benefit analysis, reference pricing, and analysis of the therapeutic characteristics of medicines in an attempt to maintain economic stability of Germany. This limits the growth opportunities. The devaluation of the Euro against the US dollar due to the eurozone crisis, over the past two to three years has limited the growth of the market in US dollar terms.

The German medical device market was worth approximately $22.1 billion in 2012 and is expected to grow to approximately $32.6 billion by 2020 at a projected CAGR of 5% over the 2013–2020. In terms of market share, cardiovascular devices (14%), in vitro diagnostics (11.3%) and orthopedic devices (10.8%) were the major segments in 2012. The key challenges faced by the German medical equipment industry are slow growth in the domestic market and pricing pressures from the German government.

With the country’s increasing elderly population and a growing awareness of chronic diseases, the medical care and diagnostic markets are expected to grow in the future. Analysis of the R&D projects being undertaken by German biotech companies suggests that approximately 110 products are in various phases of clinical development.
Note: Product cover images may vary from those shown
Adroll
adroll